Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
NEW YORK, May 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The transfection technology market is driven by factors such as increasing demand for protein production, emerging biopharmaceutical market and rising prevalence of cancer and infectious diseases, globally.
The report explains various advancements taking place in this market and analyses the global transfection technology market by types of methods and applications. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method.
The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.The transfection technology market has also been segmented on the basis of its application in biomedical research, therapeutic delivery (biotherapeutics and electro-chemotherapy and electro-immunotherapy) and protein production. Furthermore, the biomedical research segment includes transgenic models, cancer research, gene and protein expression studies and cell-based microarrays for drug discovery and development.
The report includes estimations of the global transfection technology market in terms of its value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global transfection technology market. The report provides market size and forecasts for each segment, sub-segment and geographic region with CAGR % for the period 2013 - 2019.
Geographically, transfection technology market has been segmented into four regions which include North America, Europe, Asia-Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the transfection technology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for the existing as well as the new entrants has also been discussed in the study that is expected to help in decision-making.
Some of the major players profiled in the transfection technology market report include companies such as Sigma Aldrich Corporation, SignaGen Laboratories, Lonza Group Ltd., Life Technologies, Bio-Rad Laboratories Inc., Promega Corporation and QIAGEN. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
The transfection technologymarket is segmented into the following categories:
Transfection Technology Market, by Methods
Reagent-based Method
Lipid mediated transfection (Lipofection)
Calcium phosphate
Catonic polymers
DEAE-dextran
Activated dendrimers
Magnetic beads
Instrument-based Method
Electroporation
Biolistic technology
Microinjection
Laserfection
Virus-based Method
Transfection Technology Market, by Applications
Bio-medical Research
Transgenic models
Cancer Research
Gene and protein expression studies
Cell based microarrays for drug discovery and development
Therapeutic Delivery
Biotherapeutics
Electro-chemotherapy and electro-immunotherapy
Protein Production
Transfection Technology Market, by Geography
North America
Europe
Asia-Pacific
Rest of The Worl
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
2.1.1....... Global Transfection Technology Market, by Methods, 2012 (USD Million)
2.2 Comparative Analysis: Global Transfection Technology Market, By Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview
3.1 Market Definition and Overview
3.2 Market Dynamics
3.2.1....... Drivers
3.2.1.1 Protein production promotes the use of transfection technology methods
3.2.1.2 Emerging biopharmaceutical markets in Asia boost transfection needs
3.2.2....... Restraints
3.2.2.1 High cost prevents sufficient market expansion
3.2.3....... Opportunities
3.2.3.1 Transfection technologies for stem cell research
3.3 Porters Five Force Analysis for the Global Transfection Technology Market
3.3.1....... Bargaining Power of Suppliers
3.3.2....... Bargaining Power of Buyers
3.3.3....... Threat of Substitutes
3.3.4....... Threat of New Entrants
3.3.5....... Competitive Rivalry
3.4 Market Attractiveness Analysis
3.5 Competitive Landscape
3.5.1....... Market Share Analysis by Key Players, 2012 (Value %)
Chapter 4 Global Transfection Technology Market, by Methods
4.1 Overview
4.1.1....... Global Transfection Technology Market Revenue, by Methods, 2011 – 2019 (USD Million)
4.2 Reagent-based Methods
4.2.1....... Global Reagent Based Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2.2....... Lipid Mediated Transfection (Lipofection)
4.2.2.1 Global Lipid Mediated Transfection Market Revenue, 2011 – 2019 (USD Million)
4.2.3....... Calcium Phosphate
4.2.3.1 Global Calcium Phosphate Transfection Market Revenue, 2011 – 2019 (USD Million)
4.2.4....... Cationic Polymers
4.2.4.1 Global Cationic Polymer Market Revenue, 2011 – 2019 (USD Million)
4.2.5....... DEAE dextran
4.2.5.1 Global DEAE-dextran Market Revenue, 2011 – 2019 (USD Million)
4.2.6....... Activated Dendrimers
4.2.6.1 Global Activated Dendrimers Market Revenue, 2011 – 2019 (USD Million)
4.2.7....... Magnetic Beads (Magnet-mediated transfection)
4.2.7.1 Global Magnetic Beads Transfection Market Revenue, 2011 – 2019 (USD Million)
4.3 Instrument-based Methods
4.3.1....... Global Instrument Based Method Revenue, by Types, 2011 – 2019 (USD Million)
4.3.2....... Electroporation
4.3.2.1 Global Electroporation Market Revenue, 2011 – 2019 (USD Million)
4.3.3....... Biolistic Technology
4.3.3.1 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
4.3.4....... Microinjection
4.3.4.1 Global Microinjection Market Revenue, 2011 – 2019 (USD Million)
4.3.5....... Laserfection
4.3.5.1 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
4.4 Virus-based Methods
4.4.1....... Global Virus Based Method Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Transfection Technology Market, By Application
5.1 Overview
5.1.1....... Global Transfection Technology Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Bio-medical Research
5.2.1....... Global Bio-medical Research Market Revenue, by Types, 2011 – 2019 (USD Million)
5.2.2....... Transgenic Models
5.2.2.1 Global Transgenic Model Market Revenue, 2011 – 2019 (USD Million)
5.2.3....... Cancer Research
5.2.3.1 Global Cancer Research Market Revenue, 2011 – 2019 (USD Million)
5.2.4....... Gene and Protein Expression Studies
5.2.4.1 Global Gene and Protein Expression Studies Market Revenue, 2011 – 2019 (USD Million)
5.2.5....... Cell Based Microarray for Drug Discovery and Development
5.2.5.1 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
5.3 Therapeutic Delivery
5.3.1....... Global Therapeutics Delivery Market Revenue, by Types, 2011 – 2019 (USD Million)
5.3.2....... Biotherapeutics
5.3.2.1 Global Biotherapeutics Market Revenue, 2011 – 2019 (USD Million)
5.3.3....... Electro-chemotherapy and Electro-immunotherapy
5.3.3.1 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million)
5.4 Protein Production
5.4.1....... Global Protein Production Market Revenue, 2011 – 2019 (USD Million)
Chapter 6 Global Transfection Technology Market, by Geography
6.1 Overview
6.1.1....... Global Transfection Technology Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
6.2.1....... North America Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1....... Europe Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1....... Asia-Pacific Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1....... RoW Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Recommendations
7.1 Market Strategy for Success
7.1.1....... Develop new technologies and product improvement
7.1.2....... Enhance product portfolio for stem cell research transfection
7.2 Barriers and Future Assumptions
7.2.1....... High cost is a barrier for sufficient market expansion
Chapter 8 Company Profiles
8.1 Bio-Rad Laboratories, Inc.
8.1.1....... Company Overview
8.1.2....... Financial Overview
8.1.3....... Product Portfolio
8.1.4....... Business Strategies
8.1.5....... Recent Developments
8.2 Harvard Bioscience, Inc.
8.2.1....... Company Overview
8.2.2....... Financial Overview
8.2.3....... Product Portfolio
8.2.4....... Business Strategies
8.2.5....... Recent Developments
8.3 Life Technologies Corporation
8.3.1....... Company Overview
8.3.2....... Financial Overview
8.3.3....... Product Portfolio
8.3.4....... Business Strategies
8.3.5....... Recent Developments
8.4 Lonza Group Ltd.
8.4.1....... Company Overview
8.4.2....... Financial Overview
8.4.3....... Product Portfolio
8.4.4....... Business Strategies
8.4.5....... Recent Developments
8.5 Merck KGaA
8.5.1....... Company Overview
8.5.2....... Financial Overview
8.5.3....... Product Portfolio
8.5.4....... Business Strategies
8.5.5....... Recent Developments
8.6 Mirus Bio LLC
8.6.1....... Company Overview
8.6.2....... Financial Overview
8.6.3....... Product Portfolio
8.6.4....... Business Strategies
8.6.5....... Recent Development
8.7 Polyplus-transfection S.A.
8.7.1....... Company Overview
8.7.2....... Financial Overview
8.7.3....... Product Portfolio
8.7.4....... Business Strategies
8.7.5....... Recent Developments
8.8 Promega Corporation
8.8.1....... Company Overview
8.8.2....... Financial Overview
8.8.3....... Product Portfolio
8.8.4....... Business Strategies
8.8.5....... Strategic Alliance
8.8.6....... Recent Developments
8.9 QIAGEN
8.9.1....... Company Overview
8.9.2....... Financial Overview
8.9.3....... Product Portfolio
8.9.4....... Business Strategies
8.9.5....... Recent Developments
8.10 Roche Holding AG
8.10.1..... Company Overview
8.10.2..... Financial Overview
8.10.3..... Product Portfolio
8.10.4..... Business Strategies
8.10.5..... Recent Development
8.11 Sigma-Aldrich Corporation
8.11.1..... Company Overview
8.11.2..... Financial Overview
8.11.3..... Product Portfolio
8.11.4..... Business Strategies
8.11.5..... Recent Developments
8.12 SignaGen Laboratories
8.12.1..... Company Overview
8.12.2..... Financial Overview
8.12.3..... Product Portfolio
8.12.4..... Recent Developments
8.13 Thermo Fisher Scientific, Inc.
8.13.1..... Company Overview
8.13.2..... Financial Overview
8.13.3..... Product Portfolio
8.13.4..... Business Strategies
8.13.5..... Recent Developments
List of Figures FIG. 1 Transfection Technology: Market Segmentation
FIG. 2 Global Transfection Technology Market, by Methods, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Transfection Technology Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter's Five Forces Analysis: Global Transfection Technology Market
FIG. 5 Market Attractiveness Analysis: Global Transfection Technology Market, by Geography
FIG. 6 Market Share Analysis: Transfection Technology Market, 2012 (Value %)
FIG. 7 Global Lipid Mediated Transfection Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Calcium Phosphate Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Cationic Polymer Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global DEAE-dextran Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Activated Dendrimers Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Magnetic Beads Transfection Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Magnetic Beads Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Microinjection Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Biolistic Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Virus Based Method Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Transgenic Model Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Cancer Research Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Gene and Protein Expression Studies Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Global Biotherapeutics Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 North America Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 26 Europe Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 27 Asia-Pacific Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 28 RoW Transfection Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 29 Annual Sales: Bio-Rad Laboratories, Inc., Life Science Segment, 2010 – 2012 (USD Million)
FIG. 30 Annual Sales: Harvard Bioscience, Inc., 2010 - 2012 (USD Million)
FIG. 31 Annual Sales: Life Technologies Corporation, 2010 – 2012 (USD Million)
FIG. 32 Annual Sales: Lonza Group Ltd., Bioscience Segment , 2010 – 2012 (USD Million)
FIG. 33 Annual Sales: Merck KGaA, Merck Millipore , 2010 – 2012 (USD Million)
FIG. 34 Annual Sales: QIAGEN, 2010 – 2012 (USD Million)
FIG. 35 Annual Sales: Roche Holding AG, 2010 – 2012 (USD Million)
FIG. 36 Annual Sales: Sigma-Aldrich Corporation, 2010 – 2012 (USD Million)
FIG. 37 Annual Sales: Thermo Fisher Scientific, 2010– 2012 (USD Million)
List of Tables
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
TABLE 3 Global Transfection Technology Market Revenue, by Methods, 2011 – 2019 (USD Million)
TABLE 4 Global Reagent Based Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Instrument Based Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Transfection Technology Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Global Bio-medical Research Market Revenue, by Types, 2011 – 2019(USD)
TABLE 8 Drug Delivery Methods with their Carriers/Factors
TABLE 9 Global Therapeutics Delivery Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 10 Global Transfection Technology Market Revenue, by Geography, 2011 – 2019 (USD Million)
To order this report: Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02114373/Transfection-Technology-Market-Reagent-based-method-Instrument-based-method-and-Virus-based-method---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article